Latest Innovation News

LTR Pharma has successfully completed the extractables study for its intranasal erectile dysfunction spray SPONTAN, confirming safety compliance and initiating the next phase of leachables testing to support FDA approval.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

Metallium Ltd has raised A$50 million to accelerate the commercial launch of its patented Flash Joule Heating technology in the U.S., aiming to revolutionize strategic metal recovery from waste and ore. The company is set to commission its first commercial plant in Texas by early 2026, backed by key partnerships and strong institutional support.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Black Canyon Limited’s Phase 2 drilling at the Wandanya Project confirms extensive high-grade manganese and iron mineralisation, revealing significant scale and promising exploration upside.

Aquirian Limited has secured $5 million in fresh capital to upgrade its Wubin emulsion facility and accelerate commercialization of its innovative Collar Keeper® technology, alongside a new $1.5 million tolling contract.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Assetora Australia Limited has been officially appointed as the Responsible Entity of the DomaCom Fund, lifting previous restrictions and paving the way for renewed investment activity and secondary market trading.

Papyrus Australia has successfully expanded its banana fibre technology to produce boards and flat paper products, while advancing a promising joint venture in Vietnam for high-volume production.

Papyrus Australia reported a modest net operating cash outflow of $39,000 for May 2025, maintaining a solid cash position supported by available loan facilities that extend its funding runway to over 16 months.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

Oceania Holdings Limited showcased robust operational progress and a strategic pivot towards portfolio modernization at its 2025 Annual Meeting, while announcing a new cost savings program and withholding its final dividend for FY25.